Metabolic and mitochondrial myopathies

• Published in: Zeitschrift für Rheumatologie Vol. 72; no. 3; p. 242
• Main Authors: Vorgerd, M, Deschauer, M
• Format: Journal Article
• Language: German
• Published: Germany 01-04-2013
• Subjects: Humans; Metabolic Diseases - diagnosis; Metabolic Diseases - therapy; Mitochondrial Myopathies - diagnosis; Mitochondrial Myopathies - therapy
• ISSN: 1435-1250
• DOI: 10.1007/s00393-012-1082-9

Metabolic myopathies include a broad group of diseases involving inherited enzyme defects in the various metabolic pathways and skeletal musculature. They show an extensive phenotypic variability of symptoms and different ages of manifestation. Symptoms often included intolerance to duress or permanent paresis. Some forms of metabolic myopathy, in particular mitochondriopathy, are associated with multsystemic organ participation. The diagnostics must be adjusted to individual cases and carried out in stages. Primary investigations should include blood parameters (e.g. creatine kinase measurement, muscle load tests and determination of the acylcarnitine spectrum) and a second step includes muscle biopsy for histological and enzyme investigations and special molecular genetic tests although the causative enzyme defect cannot be clarified in every case. On the other hand by means of a thorough investigation it is particularly important in patients with load intolerance to differentiate between other causes, in particular psychosomatic diseases. If this is not done there is a danger of classifying the symptoms of a metabolic myopathy as a somatoform disorder. Therapy is mostly symptom-oriented as Pompe disease is the only one which can be treated with enzyme replacement therapy.